Table of contents
About this book
This book presents an extensive study on the effectiveness of recent regulations on pharmaceutical prices in India, exploring the weaknesses in the design and implementation of pharmaceutical price controls and investigating what can be done to fix the broken system.
In addition, it examines the extent to which essential medicines are actually made affordable by price controls. The book argues that companies make the pharmaceutical price control regime largely ineffective by coordinating to increase pre-regulation prices; by diversifying horizontally away from the regulated markets and increasing prices in the unregulated markets; by manipulating trade margins; and by refusing to comply with the regulation because the penalties remains negligible.
- DOI https://doi.org/10.1007/978-3-319-93393-1
- Copyright Information Springer International Publishing AG, part of Springer Nature 2018
- Publisher Name Springer, Cham
- eBook Packages Economics and Finance
- Print ISBN 978-3-319-93392-4
- Online ISBN 978-3-319-93393-1
- Series Print ISSN 2198-0012
- Series Online ISSN 2198-0020
- Buy this book on publisher's site